Clinical Trials Logo

Clinical Trial Summary

This study is being done to learn about the medical effects, the safety, and the immunologic effects of Wheat Oral Immunotherapy (OIT) treatment. The goal of the study is to find out whether subjects can develop the ability to eat wheat (the food allergen) regularly without allergic symptoms after stopping the study treatment.


Clinical Trial Description

Food allergy affects 6-8 percent of children in the United States. Wheat is one of the eight most common foods inducing allergic reactions in the US. Current treatment for food allergy is complete avoidance of the food and to carry antihistamines and self-injectable epinephrine if an accidental reaction occurs. However, accidental exposure to allergens in processed foods may be difficult to avoid. Currently, several therapeutic strategies are being investigated to prevent and treat food allergies. Since immunotherapy injections for food allergy are associated with a high rate of allergic reactions, alternate approaches to treatment are needed. Oral (by mouth) immunotherapy (OIT) is one approach that has been tried in some studies in the treatment of food allergies. The intent of the study is to examine the clinical effects and safety of wheat OIT. This study will last 2 years. All eligible subjects will receive a wheat oral food challenge (OFC). Those who react to 1923mg or less of vital wheat gluten will be randomized to Wheat OIT or a placebo. All eligible and enrolled subjects will have a 1-year and 2-year OFC. Placebo subjects will crossover to Wheat OIT at the 1-year time point. At selected visits, blood and urine collection, physical examination, prick skin tests, and atopic dermatitis and asthma evaluations will occur. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01980992
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact
Status Completed
Phase Phase 1/Phase 2
Start date October 2013
Completion date April 13, 2017

See also
  Status Clinical Trial Phase
Completed NCT04100122 - Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Terminated NCT02341040 - Evaluation of Potential Allergenicity of New Wheat Varieties
Completed NCT01801748 - The Natural History of Wheat Hypersensitivity in Thai Children N/A
Recruiting NCT06069492 - Randomized Controlled Trial for Wheat Oral Immunotherapy N/A
Completed NCT01070368 - Accuracy Of Skin Prick Test Using In-house Wheat Extract For The Diagnosis Of IgE-mediated Wheat Allergy: A Pilot Study N/A
Terminated NCT04013763 - Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care N/A
Recruiting NCT03352193 - Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
Completed NCT01755884 - Oral Desensitization to Wheat in School Aged Children N/A
Completed NCT03487315 - Major Allergen in Wheat Anaphylaxis in Thai Population N/A